Part 2: Post-transplant Lymphoproliferative Disorders
Namrata M. Shah, MD, MPH
Hematology/Oncology Fellow, Medical College of Wisconsin, Milwaukee, WI
Timothy S. Fenske, MD
Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
Which of the following are important risk factors that contribute to the development of PTLD?